SE8405493D0
(sv)
*
|
1984-11-01 |
1984-11-01 |
Bror Morein |
Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
|
CA1267087A
(en)
*
|
1985-02-14 |
1990-03-27 |
Nicolaas Visser |
Synthetic immunogen
|
DK166762B1
(da)
*
|
1986-01-14 |
1993-07-12 |
Nederlanden Staat |
Fremgangsmaade til fremstilling af immunogenkomplekser og farmaceutisk sammensaetning indeholdende saadanne komplekser
|
US6291228B1
(en)
|
1988-08-03 |
2001-09-18 |
Vericore Limited |
Vaccine
|
NZ230747A
(en)
*
|
1988-09-30 |
1992-05-26 |
Bror Morein |
Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
|
US5721109A
(en)
*
|
1989-01-18 |
1998-02-24 |
Sawai Pharmaceutical Co., Ltd. |
Method for diagnosing infection caused by acid-fast bacterium
|
AU638970B2
(en)
*
|
1989-01-23 |
1993-07-15 |
Auspharm International Limited |
Vaccine composition
|
CA2017507C
(en)
*
|
1989-05-25 |
1996-11-12 |
Gary Van Nest |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
US5246707A
(en)
*
|
1990-04-26 |
1993-09-21 |
Haynes Duncan H |
Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes
|
US5091188A
(en)
*
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
CA2108266C
(en)
*
|
1991-04-19 |
2003-06-03 |
Albert J. Owen |
Convertible microemulsion formulations
|
US5688761A
(en)
*
|
1991-04-19 |
1997-11-18 |
Lds Technologies, Inc. |
Convertible microemulsion formulations
|
GB9110808D0
(en)
*
|
1991-05-17 |
1991-07-10 |
Retroscreen Ltd |
Aids vaccine and method for its production
|
CZ278863B6
(en)
*
|
1992-09-07 |
1994-07-13 |
Galena |
Medicinal preparations with n-methylated cyclic undecapeptides
|
ES2053402B1
(es)
*
|
1993-01-15 |
1995-02-01 |
Hipra Lab Sa |
Metodo de preparacion de vacunas inactivadas y vacunas vivas adyuvantadas asi como las vacunas obtenidas por dicho metodo.
|
NZ262821A
(en)
*
|
1993-02-26 |
1997-03-24 |
Cambridge Biotech Corp |
Detecting the ability of borrelia burgdofori antiserum to inhibit b. burgdofori growth and vaccines against the bacteria especially for treating lyme disease
|
US5902565A
(en)
*
|
1993-12-24 |
1999-05-11 |
Csl Limited |
Spray dried vaccine preparation comprising aluminium adsorbed immunogens
|
US5739118A
(en)
|
1994-04-01 |
1998-04-14 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
US5688772A
(en)
*
|
1994-08-01 |
1997-11-18 |
University Of Saskatchewan |
Quinoa saponin compositions and methods of use
|
US5597807A
(en)
*
|
1994-08-01 |
1997-01-28 |
University Of Saskatchewan |
Quinoa saponin compositions and methods of use
|
US5962428A
(en)
*
|
1995-03-30 |
1999-10-05 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
FR2733151B1
(fr)
*
|
1995-04-20 |
1997-05-23 |
Seppic Sa |
Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
|
US6689370B1
(en)
|
1995-04-20 |
2004-02-10 |
Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) |
Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
|
US6117432A
(en)
*
|
1995-04-20 |
2000-09-12 |
Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) |
Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
|
US20010053365A1
(en)
*
|
1995-04-25 |
2001-12-20 |
Smithkline Beecham Biologicals S.A. |
Vaccines
|
DE69637441T2
(de)
|
1995-10-17 |
2009-03-05 |
Jagotec Ag |
Verabreichung unlöslicher arzneistoffe
|
WO1997015316A1
(en)
*
|
1995-10-27 |
1997-05-01 |
Merck & Co., Inc. |
Conjugates of gonadotropin releasing hormone
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US6716823B1
(en)
|
1997-08-13 |
2004-04-06 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom, and uses thereof
|
US6706693B1
(en)
|
1997-08-13 |
2004-03-16 |
The Uab Research Foundation |
Vaccination by topical application of genetic vectors
|
US6348450B1
(en)
|
1997-08-13 |
2002-02-19 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom and uses thereof
|
US20030125278A1
(en)
*
|
1997-08-13 |
2003-07-03 |
Tang De-Chu C. |
Immunization of animals by topical applications of a salmonella-based vector
|
US20030045492A1
(en)
*
|
1997-08-13 |
2003-03-06 |
Tang De-Chu C. |
Vaccination by topical application of recombinant vectors
|
CA2302522C
(en)
*
|
1997-08-29 |
2010-08-17 |
Aquila Biopharmaceuticals, Inc. |
Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
|
GB9718901D0
(en)
*
|
1997-09-05 |
1997-11-12 |
Smithkline Beecham Biolog |
Vaccine
|
US6524592B2
(en)
*
|
1997-10-17 |
2003-02-25 |
American Home Products Corporation |
Veterinary vaccines
|
AUPP060097A0
(en)
*
|
1997-11-28 |
1998-01-08 |
Commonwealth Scientific And Industrial Research Organisation |
Adjuvant system for enhanced response
|
US20070059327A2
(en)
*
|
1998-01-15 |
2007-03-15 |
Wyeth |
Streptococcus equi compositions and methods of use
|
CA2320807C
(en)
*
|
1998-02-11 |
2011-01-18 |
Research Triangle Pharmaceuticals |
Method and composition for treatment of inflammatory conditions
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
WO1999061001A1
(en)
|
1998-05-29 |
1999-12-02 |
Rtp Pharma Inc. |
Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
|
DE69912441T2
(de)
*
|
1998-08-19 |
2004-08-19 |
Skyepharma Canada Inc., Verdun |
Injizierbare wässerige propofoldispersionen
|
AU767154B2
(en)
*
|
1998-11-20 |
2003-10-30 |
Skyepharma Canada Inc. |
Dispersible phospholipid stabilized microparticles
|
CA2370697C
(en)
*
|
1999-04-19 |
2012-03-06 |
Smithkline Beecham Biologicals S.A. |
Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
|
GB9908885D0
(en)
*
|
1999-04-19 |
1999-06-16 |
Smithkline Beecham Biolog |
Vccine
|
US20040009936A1
(en)
*
|
1999-05-03 |
2004-01-15 |
Tang De-Chu C. |
Vaccine and drug delivery by topical application of vectors and vector extracts
|
CA2383233C
(en)
*
|
1999-09-21 |
2010-06-08 |
Rtp Pharma Inc. |
Surface modified particulate compositions of biologically active substances
|
EP1276465B1
(en)
|
2000-04-20 |
2014-03-12 |
Jagotec AG |
Improved water-insoluble drug particle process
|
CA2420597C
(en)
|
2000-08-31 |
2011-05-17 |
Rtp Pharma Inc. |
Milled particles
|
CA2423336C
(en)
*
|
2000-09-20 |
2011-03-08 |
Rtp Pharma Inc. |
Stabilised fibrate microparticles
|
US8586094B2
(en)
*
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
ES2377077T3
(es)
*
|
2000-10-18 |
2012-03-22 |
Glaxosmithkline Biologicals S.A. |
Vacunas que comprenden al antígeno MAGE unido a un fragmento de proteína D
|
JP2004523552A
(ja)
*
|
2001-02-22 |
2004-08-05 |
スカイファーマ・カナダ・インコーポレーテッド |
低減した摂食−絶食効果を伴うフィブラート−スタチンの組合わせ
|
WO2002067899A1
(en)
*
|
2001-02-28 |
2002-09-06 |
Akzo Nobel N.V. |
Injectable water-in-oil emulsions
|
US20030138434A1
(en)
*
|
2001-08-13 |
2003-07-24 |
Campbell Robert L. |
Agents for enhancing the immune response
|
US6861410B1
(en)
*
|
2002-03-21 |
2005-03-01 |
Chiron Corporation |
Immunological adjuvant compositions
|
CA2483468A1
(en)
*
|
2002-04-24 |
2003-11-06 |
Universite Libre De Bruxelles |
Mutated hpv-16 e7 polypeptide, pharmaceutical composition comprising it and its preparation process
|
SI1613346T1
(sl)
|
2003-04-04 |
2013-02-28 |
Pah Usa 15 Llc |
Mikrofluidizirane emulzije olja v vodi in sestava cepiv
|
KR20070120970A
(ko)
*
|
2005-02-23 |
2007-12-26 |
유에이비 리서치 파운데이션 |
알킬-글리코시드로 증진된 예방접종
|
CA2647939A1
(en)
*
|
2006-03-30 |
2007-11-08 |
Embrex, Inc. |
Methods and compositions for vaccination of poultry
|
EP2197497B1
(en)
*
|
2007-09-27 |
2016-06-01 |
ImmunoVaccine Technologies Inc. |
Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
|
US20100209452A1
(en)
*
|
2007-10-03 |
2010-08-19 |
Immunovaccine Technologies, Inc |
Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
|
US20110070298A1
(en)
*
|
2008-06-05 |
2011-03-24 |
Immunovaccine Technologies Inc. |
Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance
|
CA2850857C
(en)
|
2011-10-06 |
2022-07-26 |
Immunovaccine Technologies Inc. |
Liposome compositions comprising an adjuvant that activates or increases the activity of tlr2 and uses thereof
|